OTC Watch

All stocks / VNOV

VitaNova Life Sciences Corp VNOV

VitaNova Life Sciences (VNOV): no warning signs from our rules in the last 12 months and the latest annual figures in plain language. Each fact links to its SEC filing.

Estimated float OTCIDNew York, USA
Live quote on OTC Markets

Market listing

Full name
VITANOVA LIFE SCIENCES CORP
Market tier
OTC Pink Current
Trading status
Active
Last trade
Nov 13
Source: Stockwatch, 2026-11-17

The financial report, and what it means

Annual figures to 2026-04-30
The report says
Revenue
$3,025,538
Net loss
($37,304)
What it means

It spends more than it earns

Under strain

Customers paid it $3 million in the year. It lost $37,304. For every $1 that came in, about $1.01 went out.

The report says
Cash and cash equivalents
$1,597,217
Net cash from operating activities
$814,407
What it means

The business brings in cash

Steady

Day-to-day business added $814,407 in cash over the year. It had $1.6 million in the bank.

The report says
Total assets
$2,446,561
Total liabilities
$395,781
What it means

It owns more than it owes

Steady

Everything the company owns adds up to $2.4 million. Its debts and unpaid bills add up to $395,781. That is about $0.16 owed for every $1 owned.

What this adds up to

1 of 3 checks show strain. It spends more than it earns. These are facts from the company's own reports, not a recommendation.

Signals

Estimated float2026-09-14

Estimated float about 8,337,454 shares as of 2026-09-14: 8,337,454 outstanding minus 0 held by 0 reporting insider(s).

Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record

Shares outstanding

Source: SEC filings
2025-09-12
25.0M
2025-10-31
25.0M
2025-12-15
25.0M
2026-03-11
8.3M
2026-04-30
8.3M
2026-07-28
8.3M
2026-07-31
8.3M
2026-09-14
8.3M

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Recent filings

2026-09-14 10-QFORM 10-Q FOR JUL 2026
2026-07-29 10-KFORM 10-K FOR APR 2026
2026-03-18 8-KCURRENT REPORT
2026-03-16 10-QFORM 10-Q FOR JAN 2026
2026-02-25 8-KCURRENT REPORT
2026-01-27 8-KCURRENT REPORT
2026-01-13 8-KFORM 8-K
2025-12-15 10-QFORM 10-Q FOR OCT 2025

Common questions about VNOV

Does VNOV file reports with the SEC?

Yes. VitaNova Life Sciences files with the SEC under company number 0001699709. The most recent filing we hold is a 10-Q dated 2026-09-14.

Source record

How many VNOV shares are outstanding?

8,337,454 shares as of 2026-09-14, as reported to the SEC.

Source record

Has VNOV filed reports late?

We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.

Is VitaNova Life Sciences making money?

Customers paid it $3 million in the year. It lost $37,304. For every $1 that came in, about $1.01 went out. (Annual figures to 2026-04-30. Facts from the company's own report, not a recommendation.)

Source record